InvestorsObserver is giving GW Pharmaceuticals PLC- ADR (GWPH) an Analyst Rating Rank of 80, meaning GWPH is ranked higher by analysts than 80% of stocks. The average projection by analysts for GWPH is $182.692 over the next 12 months and analyst’s classify the stock as a Strong Buy
Why are Analyst Ratings Important?
Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions before a quarterly report that could be worse than expected.
InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.
What's Happening With GW Pharmaceuticals PLC- ADR Stock Today?
GW Pharmaceuticals PLC- ADR (GWPH) stock is trading at $122.59 as of 11:02 AM on Tuesday, May 19, an increase of $2.39, or 1.99% from the previous closing price of $120.20. The stock has traded between $119.00 and $123.78 so far today. Volume today is less active than usual. So far 86,490 shares have traded compared to average volume of 420,022 shares.
